glp-1 startups GLP-1 startups and emerging players GLP-1 Agonists Market Report 2025-2033,

Int J Mol Sci (2021) 22(2):860

Long-acting glucagon-like peptide (GLP)-1 analogs are currently available in treating diabetes with widely established safety and extensively evaluated efficacy

It is a cardiometabolic condition

So, the most significant piece of direct evidence published so far is a 2025 rat study from the Journal of Neuroimmune Pharmacology [2], and I want to be clear upfront: its a rat study

Chronic carbohydrate restriction Though there are many health benefits of a ketogenic diet in the short-term, long-term it can lead to hypothyroidism

Moreno emphasizes that average does not tell the full story